GSK, TCS to jointly set up global drug development support centre

New Delhi, Mar 27 (UNI) Aiming to cater to the demands of growing GSK pipeline, Pharma major GlaxoSmithKline (GSK) and global IT giant Tata Consultancy Services (TCS) today entered into a multi-million dollar contract to set up a global drug development support centre in Mumbai.

Under the contract, TCS will provide a variety of services in clinical research, including Clinical Data Management and Clinical Submissions Support.

''This strategic partnership with TCS represents a significant step towards GSK's vision of leveraging key talent globally to develop innovative medicines,'' said Dr Amber Salzman, Senior Vice President, Development Operations, GSK.

Dr Salzman added that GSK has chosen to partner with TCS because of its strong record in knowledge process outsourcing, underpinned by operational excellence.

GSK is the leading research-based pharmaceutical company in the country by sales. The pharmaceuticals business of GSK India employs 2,425 people.

The centre will house a TCS team of highly skilled professionals including pharmacologists, PhDs in life sciences, post-graduates in Pharmacy, and individuals with a life sciences background experienced in clinical-data management and programming.

TCS will bring in its strong domain expertise, superior talent management skills, flexible operating models, proven transition capabilities and performance driven processes.

UNI